Agios Pharmaceuticals | GJELD



Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Bayer EUR 40.7B 465M 2024-12
Biogen USD 6.3B 1.9M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Daiichi Sankyo JPY 101.33B 97M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 0 0 2025-01
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Merck USD 37.11B 1.02B 2024-12
Moderna USD 745M 683M 2025-03
Novartis USD 31.26B 828M 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Agios Pharmaceuticals GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.